mcc-555 has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baek, SJ; Cekanova, M; Fischer, SM; McEntee, MF; Renes, IB; Van Seuningen, I; Yamaguchi, K; Yoon, JH | 1 |
1 other study(ies) available for mcc-555 and Lung Neoplasms
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor ligand MCC-555 suppresses intestinal polyps in ApcMin/+ mice via extracellular signal-regulated kinase and peroxisome proliferator-activated receptor-dependent pathways.
Topics: Adenomatous Polyposis Coli Protein; Animals; Cell Line, Tumor; Colorectal Neoplasms; Extracellular Signal-Regulated MAP Kinases; Gene Expression Regulation, Neoplastic; Humans; Intestinal Polyps; Ligands; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mucin-2; Mucins; Peroxisome Proliferator-Activated Receptors; RNA, Messenger; Thiazolidinediones; Transcription, Genetic | 2008 |